Pharmacology Laboratory, Zhongshan Hospital, Guangzhou University of Chinese Medicine, Zhongshan 528401, China.
Shenzhen Baoan Authentic TCM Therapy Hospital, Shenzhen 518101, China.
Oxid Med Cell Longev. 2022 Aug 16;2022:2042163. doi: 10.1155/2022/2042163. eCollection 2022.
Inflammatory bowel disease (IBD), a widespread intestinal disease threatening human health, is commonly accompanied by secondary liver injury (SLI). Pyroptosis and oxidative stress act as an important role underlying the pathophysiology of SLI, during which a large number of proinflammatory cytokines and oxidative intermediates can be produced, thereby causing the liver severely damaged. Suppression of pyroptosis and oxidative damage can be considered one of the critical strategies for SLI therapy. Garlic, a natural food with eatable and medicinal functions, is widely used in people's daily life. There is no study about the alleviation of garlic against IBD accompanied with SLI. This study is aimed at investigating the efficacy of the polysaccharides from garlic (PSG) in treating IBD and SLI, as well as its pharmacological mechanism. The results showed that PSG significantly alleviated dextran sulfate sodium-induced IBD determined by evaluating the bodyweight loss, disease activity index, colon length, and colonic pathological examination of mice. PSG significantly reduced the colonic inflammation by reversing the levels of myeloperoxidase, diamine oxidase activity, iNOS, and COX2 and strengthened the intestinal barrier by increasing the expressions of ZO1, occludin, and MUC2 of IBD mice. Furthermore, PSG strongly alleviated SLI determined by assessing the liver morphological change, liver index, levels of ALT and AST, and liver pathological change of mice. Mechanically, PSG reduced the high levels of LPS, IL-1, IL18, NLRP3, gasdermin D, caspase 1, ASC, TLR4, MyD88, NF-B, phospho-NF-B, while it increased IL-10 in the livers of mice, indicating that PSG alleviated SLI by suppressing inflammation and pyroptosis. Additionally, PSG significantly inhibited the oxidative damage in the liver tissues of SLI mice by reducing the levels of ROS, MDA, Keap-1, 8-OHDG, and phospho-H2AX and increasing the levels of GPX4, SOD2, HO1, NQO1, and Nrf2. These findings suggested that the garlic polysaccharides could be used to treat IBD accompanied with SLI in humans.
炎症性肠病(IBD)是一种威胁人类健康的广泛的肠道疾病,常伴有继发性肝损伤(SLI)。细胞焦亡和氧化应激在 SLI 的病理生理学中起着重要作用,在此过程中会产生大量的促炎细胞因子和氧化中间体,从而导致肝脏严重受损。抑制细胞焦亡和氧化损伤可被视为 SLI 治疗的关键策略之一。大蒜作为一种具有食用和药用功能的天然食品,在人们的日常生活中被广泛应用。目前尚无关于大蒜缓解 IBD 伴 SLI 的研究。本研究旨在探讨大蒜多糖(PSG)治疗 IBD 和 SLI 的疗效及其药理学机制。结果表明,PSG 显著缓解了葡聚糖硫酸钠诱导的 IBD,通过评估小鼠的体重减轻、疾病活动指数、结肠长度和结肠病理检查来确定。PSG 通过逆转髓过氧化物酶、二胺氧化酶活性、iNOS 和 COX2 的水平,并通过增加 IBD 小鼠的 ZO1、occludin 和 MUC2 的表达来增强肠道屏障,从而显著减轻了结肠炎症。此外,PSG 强烈缓解了由评估小鼠肝脏形态变化、肝指数、ALT 和 AST 水平以及肝病理变化来确定的 SLI。在机制上,PSG 降低了 LPS、IL-1、IL18、NLRP3、gasdermin D、caspase 1、ASC、TLR4、MyD88、NF-B、磷酸化-NF-B 的高水平,同时增加了小鼠肝脏中的 IL-10,表明 PSG 通过抑制炎症和细胞焦亡来缓解 SLI。此外,PSG 通过降低 SLI 小鼠肝脏组织中 ROS、MDA、Keap-1、8-OHDG 和磷酸化-H2AX 的水平,增加 GPX4、SOD2、HO1、NQO1 和 Nrf2 的水平,显著抑制了氧化损伤。这些发现表明,大蒜多糖可用于治疗人类 IBD 伴 SLI。